Table 1.
Patients population characteristics.
| Age, years | |
|---|---|
| Mean | 62 |
| Range | 47-88 |
| Sex | n.(%) |
| Male | 46 (66%) |
| Female | 24 (34%) |
| Line of therapy | |
| 1st | 70 (100%) |
| Treatment received CT plus Bev CT alone |
56 (80%) 14 (20%) |
| Location of primary tumor | |
| Left | 47 (67%) |
| Right | 23 (33%) |
| Histology | |
| Adenocarcinoma | 70 (100%) |
| Metastatic sites | |
| liver | 63 (90%) |
| other | 7 (10%) |
| RAS/BRAFmutation tissue/plasma baseline | |
| Mutated KRAS G12D KRAS G12V KRAS G12A KRAS G12R/S KRAS G12C KRAS Q61 KRAS A146T KRAS G13D NRAS G12D NRAS G12C NRAS Q61R NRAS A146T BRAF V600E |
70(100%) 16 (22%) 15 (21%) 5 (7%) 2 (3%) 6 (8%) 5 (7%) 5 (7%) 7 (10%) 3 (4%) 1(1%) 1 (1%) 1(1%) 3 (4%) |